PICHIRI, Isabella
 Distribuzione geografica
Continente #
EU - Europa 3.384
NA - Nord America 3.280
AS - Asia 1.808
SA - Sud America 274
Continente sconosciuto - Info sul continente non disponibili 130
AF - Africa 68
OC - Oceania 3
Totale 8.947
Nazione #
US - Stati Uniti d'America 3.197
GB - Regno Unito 1.316
RU - Federazione Russa 984
SG - Singapore 645
CN - Cina 624
IT - Italia 238
BR - Brasile 222
VN - Vietnam 168
SE - Svezia 164
DE - Germania 152
FR - Francia 136
IE - Irlanda 126
HK - Hong Kong 122
FI - Finlandia 120
KR - Corea 77
CA - Canada 49
UA - Ucraina 32
IN - India 29
BD - Bangladesh 27
ID - Indonesia 27
BE - Belgio 18
JP - Giappone 18
ZA - Sudafrica 18
AR - Argentina 17
ES - Italia 16
MX - Messico 16
NL - Olanda 14
PL - Polonia 13
TR - Turchia 11
EC - Ecuador 10
NG - Nigeria 10
GR - Grecia 8
AZ - Azerbaigian 7
CR - Costa Rica 7
GH - Ghana 7
IQ - Iraq 7
PK - Pakistan 7
PY - Paraguay 7
CO - Colombia 6
UZ - Uzbekistan 6
CH - Svizzera 5
CZ - Repubblica Ceca 5
DK - Danimarca 5
DZ - Algeria 5
ET - Etiopia 5
JM - Giamaica 5
LT - Lituania 5
RO - Romania 5
AT - Austria 4
BO - Bolivia 4
EG - Egitto 4
JO - Giordania 4
MY - Malesia 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
EE - Estonia 3
IL - Israele 3
PA - Panama 3
SA - Arabia Saudita 3
TN - Tunisia 3
AL - Albania 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
CL - Cile 2
HR - Croazia 2
IR - Iran 2
KE - Kenya 2
KG - Kirghizistan 2
LV - Lettonia 2
MA - Marocco 2
PE - Perù 2
PT - Portogallo 2
QA - Qatar 2
TG - Togo 2
UY - Uruguay 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BF - Burkina Faso 1
BG - Bulgaria 1
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CV - Capo Verde 1
CY - Cipro 1
EU - Europa 1
HN - Honduras 1
HU - Ungheria 1
LS - Lesotho 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
Totale 8.816
Città #
Southend 1.199
Moscow 393
Ashburn 392
Singapore 338
Chandler 321
San Jose 273
Dallas 265
Ann Arbor 185
Jacksonville 184
Beijing 147
Dublin 126
Woodbridge 125
Hong Kong 118
Houston 103
Council Bluffs 101
Verona 96
Los Angeles 64
Jinan 62
New York 57
Wilmington 56
Ho Chi Minh City 55
The Dalles 49
Nanjing 45
Lawrence 42
Princeton 42
Helsinki 38
Lancaster 36
Munich 34
Santa Clara 34
Buffalo 29
Shenyang 28
Hanoi 26
Orem 24
São Paulo 23
Seoul 22
Dong Ket 20
Tianjin 20
Frankfurt am Main 19
Hebei 19
Brussels 18
Turku 18
Columbus 17
Jakarta 17
Tokyo 17
Boardman 16
Nanchang 16
Toronto 15
Changsha 14
Atlanta 13
Dearborn 13
Milan 13
Montreal 13
Ningbo 13
Redondo Beach 13
Zhengzhou 13
London 12
San Francisco 12
Brooklyn 11
Kent 11
Phoenix 11
Warsaw 11
Cagliari 10
Chicago 10
Johannesburg 10
Taizhou 10
Abuja 9
Chennai 9
Denver 9
Redwood City 9
Shanghai 9
Sindelfingen 9
Falls Church 8
Haiphong 8
Hangzhou 8
Nikaia 8
Redmond 8
Taiyuan 8
Washington 8
Accra 7
Baku 7
Da Nang 7
Guayaquil 7
Haikou 7
Jiaxing 7
Poplar 7
Rio de Janeiro 7
San José 7
Ankara 6
Belo Horizonte 6
Boston 6
Brasília 6
Detroit 6
Nuremberg 6
Stockholm 6
Tashkent 6
Addis Ababa 5
Barnet 5
Campinas 5
Düsseldorf 5
Fuzhou 5
Totale 5.803
Nome #
American Diabetes Association 75th Scientific Meeting - Epidemiology/Genetics Section; Poster 1563-P: Pancreatic Beta-Cell Function, Insulin Sensitivity, and Metabolic Phenotypes in Type 2 Diabetes at the Time of Diagnosis—The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 793
Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease. 276
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events. A randomized controlled trial. 267
Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance 261
Glycated haemoglobin is inversely related to serum vitamin d levels in type 2 diabetic patients. 248
Relationship of Chronic Vascular Complications with Beta-Cell Dysfunction and Insulin Resistance in Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 220
Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Chronic Kidney Disease in Patients With Type 1 Diabetes. 216
Association between decreasing estimated glomerular filtration rate and risk of cardiac conduction defects in patients with type 2 diabetes 214
Primary cutaneous B-cell lymphoma and chronic leg ulcers in a patient with type 2 diabetes 213
Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes. 212
Genetic variability of G6PC2 influences beta cell function and insulin sensitivity in patients with newly diagnosed type 2 diabetes 211
American Diabetes Association - 75th Scientific Meeting; Section: Epidemiology/Genetics; Poster n. 1581-P: "Nonalcoholic Fatty Liver Disease Is Associated with Heart Valve Calcification in Type 2 Diabetes" 211
Interleukin-6 as a potential positive modulator of human beta-cell function: an exploratory analysis-the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 6 208
Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes. 207
Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes 207
NAFLD, diabete tipo 2, malattia cardiovascolare? 206
Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9 203
Associazione tra epatopatia steatosica non alcolica (NAFLD) e malattia renale cronica in pazienti affetti da diabete mellito tipo 1. 202
Lower levels of 25-hydroxyvitamin D3 are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes. 202
Prevalence of Cardiovascular Autonomic Neuropathy in a Cohort of Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 202
Nonalcoholic fatty liver disease is associated with aortic valve sclerosis in patients with type 2 diabetes mellitus. 201
Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes 198
'Case of the Month' from the University of Verona, Italy-navigating the medical and surgical challenges of urinary bladder paraganglioma: insights from a clinical case 198
Nonalcoholic Fatty Liver Disease Is Associated With Ventricular Arrhythmias in Patients With Type 2 Diabetes Referred for Clinically Indicated 24-Hour Holter Monitoring 195
Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function 191
Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: The Verona Diabetic Foot Screening Program. 188
Hyperuricemia is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes 186
Hemostatic and fibrinolytic abnormalities in endocrine diseases: a narrative review. [Review] 185
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 184
Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus 182
Diabetic retinopathy is associated with an increased incidence of cardiovascular events in type 2 diabetic patients. 181
Increased prevalence of chronic kidney disease in patients with type 1 diabetes and non-alcoholic fatty liver. 175
Relation of elevated serum uric acid levels to first-degree heart block and other cardiac conduction defects in hospitalized patients with type 2 diabetes 164
Glomerular filtration rate decline in T2DM following diagnosis. The Verona newly diagnosed diabetes study-12 164
Increased prevalence of cardiovascular disease in type 1 diabetic patients with non-alcoholic fatty liver disease. 163
Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes 156
Triglyceride-high-density lipoprotein cholesterol is associated with microvascular complications in type 2 diabetes mellitus. 153
Vitamin D, thrombosis, and haemostasis: more than skin deep. [Review] 143
Iperuricemia e rischio cardiovascolare. [Review] 138
Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. 133
Non-alcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome. [Review] 132
Steatosi epatica non alcolica nel diabete mellito. (Rassegna) 125
Insulin resistance and beta‐cell dysfunction in newly diagnosed type 2 diabetes: Expression, aggregation and predominance. Verona Newly Diagnosed Type 2 Diabetes Study 10 117
Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: just a coincidence? [Review] 116
Totale 8.947
Categoria #
all - tutte 26.944
article - articoli 23.181
book - libri 0
conference - conferenze 3.220
curatela - curatele 0
other - altro 543
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.888


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022241 0 0 0 16 17 51 4 25 12 6 33 77
2022/2023850 58 106 64 136 66 205 8 63 103 4 17 20
2023/2024439 17 28 37 51 49 86 6 15 3 47 85 15
2024/20251.043 55 54 43 194 73 53 84 41 149 30 90 177
2025/20263.253 209 157 285 533 894 205 274 170 212 195 49 70
2026/2027415 58 77 108 172 0 0 0 0 0 0 0 0
Totale 8.947